作者: Stefan Lohse , Christina Brunke , Stefanie Derer , Matthias Peipp , Peter Boross
关键词:
摘要: Background: IgA constitutes a promising antibody isotype, which requires optimization before immunotherapeutic application. Results: P221R-mutated and wild type IgA2m(1) antibodies were similarly effective in killing tumor cells recruiting myeloid effector cells. Conclusion: Improved constitute next generation for therapy. Significance: These studies support the clinical development of therapeutic antibodies.